Irish drug company Amarin says sales from Vascepa, its one cardiovascular drug for 2019, will be at or above the upper end of its previous guidance

Irish drug company Amarin says sales from its one cardiovascular drug for 2019 will be at or above the upper end of its previous guidance – indicating(...)

Prof Ruth Maher, inventor of a non invasive home treatment for stress urinary incontinence called Innovo, holding an ultrasound showing the impact of her device on the pelvic floor. Photograph: Alan Betson/The Irish Times

Life could have been quite different for Ruth Maher. She might now be edging toward retirement from the Electricity Supply Board (ESB). Instead, she c(...)

Cystic Fibrosis Ireland chief executive Philip Watt: ‘We are shaking with excitement at this news.’ File photograph: Tom Honan

A groundbreaking new therapy to treat the vast majority of people with cystic fibrosis has been approved for Irish patients. The drug, Trikafta, has (...)

US medicines regulator, the Food and Drug Administration, has cleared a major increase in the patients that can access a heart drug from small Irish pharma Amarin.

Shares in Amarin jumped on news that it had won the backing of an FDA advisory panel to sell its heart drug Vascepa to a wider group of patients. The(...)

‘It truly is a remarkable time of hope and progress in CF care in Ireland and worldwide.’ Photograph: Science Photo Library

A groundbreaking new therapy to treat the vast majority of people with cystic fibrosis could be available in Ireland as early as next summer, accordin(...)

Altria wrote down the value of its investment in Juul by $4.5 billion as the ecigarette start-up comes under increasing pressure from regulators over the health effects of vaping. Photograph: Robyn Beck/AFP via Getty Images

Altria wrote down the value of its investment in Juul by $4.5 billion as the ecigarette start-up comes under increasing pressure from regulators over (...)

Biogen said more data had become available after the two aducanumab studies were discontinued, resulting in a new analysis that showed one of the trials met the main goal. Photograph: Reuters

Biogen revived plans on Tuesday to seek US approval for Alzheimer’s treatment aducanumab, surprising investors and saying data from more patients in t(...)

Johnson & Johnson is recalling a shipment of baby powder after the US Food and Drug Administration discovered evidence of asbestos, the company said on Friday. Photograph: Jens Mortensen/The New York Times

Johnson & Johnson said on Friday it is recalling around 33,000 bottles of baby powder in the United States after US health regulators found trace (...)

Julia Vitarello with her daughter Mila (8) who has a rare neurological disorder, at their home in Colorado. Photograph: Nick Cote/The New York Times

A new drug, created to treat just one patient, has pushed the bounds of personalised medicine and has raised unexplored regulatory and ethical questio(...)

Johnson & Johnson has been fined by a US court for its marketing of Risperdal. Photograph: JB Reed/Bloomberg

A Philadelphia jury on Tuesday hit Johnson & Johnson with an $8 billion verdict over its marketing of the anti-psychotic drug Risperdal, siding wi(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »